PetMed Express, Inc.
PETS
$1.82
-$0.08-3.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -19.86% | -15.65% | -21.75% | -23.57% | -22.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.86% | -15.65% | -21.75% | -23.57% | -22.70% |
| Cost of Revenue | -19.29% | -18.81% | -12.91% | -18.64% | -22.03% |
| Gross Profit | -21.32% | -8.25% | -41.38% | -33.87% | -24.34% |
| SG&A Expenses | -18.42% | -41.63% | 18.47% | 6.39% | 47.87% |
| Depreciation & Amortization | -5.91% | 17.02% | 51.26% | 37.39% | 32.66% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.48% | -27.09% | -2.07% | -9.90% | -6.02% |
| Operating Income | 8.07% | 70.31% | -4,240.25% | -932.21% | -249.48% |
| Income Before Tax | 82.04% | 30.41% | -4,256.20% | -1,020.11% | -824.60% |
| Income Tax Expenses | 44.44% | -101.80% | -97.63% | 100.64% | -99.06% |
| Earnings from Continuing Operations | 82.01% | 65.12% | -1,392.64% | -466.29% | -1,009.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.01% | 65.12% | -1,392.64% | -466.29% | -1,009.75% |
| EBIT | 8.07% | 70.31% | -4,240.25% | -932.21% | -249.48% |
| EBITDA | 9.16% | 86.24% | -699.33% | -293.76% | -171.87% |
| EPS Basic | 82.78% | 65.77% | -1,364.43% | -461.29% | -999.18% |
| Normalized Basic EPS | 13.55% | 81.97% | -31,240.00% | -683.16% | -238.08% |
| EPS Diluted | 82.82% | 65.72% | -1,364.43% | -472.73% | -1,016.67% |
| Normalized Diluted EPS | 13.55% | 81.97% | -31,240.00% | -694.28% | -240.94% |
| Average Basic Shares Outstanding | 4.47% | 1.91% | 1.81% | 1.41% | 1.18% |
| Average Diluted Shares Outstanding | 4.47% | 1.91% | 1.81% | -0.24% | -0.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 0.93% | -1.08% | -1.00% |